SEARCH · Search PubMed

Results for “Hemoglobin Level”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

SourceResearch connectionFrom yearThrough year

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 127 records · Page 7Linked to original sources

PubMed1989

Glycosylated hemoglobin levels in Sudanese sickle cell anemia patients.

Glycosylated hemoglobin was measured, by a colorimetric method, in 49 patients with sickle cell anemia attending Khartoum Teaching Hospital. The level obtained (4.9%, SD 1.3) was significantly lower than the control value (5.6%, SD 0.2; p less than 0.0025). Expressed as percentage of the control value, the glycosylated hemoglobin level in these patients was 81%. This falls midway between the 90% reported in a benign form of sickle cell anemia in Saudi Arabia and the 58% reported in a severe form in an American Black group, which gives support to the observed heterogeneity of sickle cell anemia. Alternatively, glycosylated hemoglobin level in 27 subjects with sickle cell trait (5.6%, SD 0.2) was identical to that of the controls. The state of hemolysis in the sickle cell anemia patients, as indicated by bilirubin levels, did not correlate with the glycosylated hemoglobin values. Although glycosylated hemoglobin measurement is affected by red cell survival, it does not reflect the state of ongoing hemolysis.

Anemia, Sickle Cell↗

PubMed2003

Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer.

Anemia is a common complication of cancer that has been associated with poor response to treatment and decreased survival in many malignancies. A retrospective chart review was undertaken to determine the effects of hemoglobin (Hb) levels, measured prior to initiation of chemotherapy and before each chemotherapy cycle, and clinical prognostic factors (e.g., age, tumor stage, residual tumor size, hematologic parameters, and type of health insurance) in 250 ovarian cancer patients treated between 1985 and 1998. All patients were scheduled to receive at least 6 courses of systemic chemotherapy. None of the patients received recombinant human erythropoietin. The difference between observed overall survival and its predicted value was computed by multiple regression analysis for each patient with respect to prognostic factors. Hemoglobin levels prior to and during chemotherapy were identified as a prognostic factor for overall survival. Hemoglobin levels > or =12 g/dl were significantly associated with prolonged overall survival (P<0.001). In addition, Hb level correlated with scheduled completion of chemotherapy, overall therapeutic success, tumor stage, age at diagnosis, and residual tumor size (all, P<0.005). Hemoglobin level represents an important prognostic factor for patients with ovarian cancer. This finding supports the use of measures to maintain adequate Hb levels, such as treatment with recombinant human erythropoietin, to improve patient survival.

Adult↗

PubMed2002

Erythropoietin-mediated decrease of the redox-sensitive transcription factor NF-kappaB is inversely correlated with the hemoglobin level.

The aim of this study was to determine the effect of rh-EPO on the redox-sensitive transcription factor (NF-kappaB) in vivo and in vitro. Ten patients (7 female, 3 male), mean age 69.2 +/- 11 years, with end-stage renal failure and anemia prior to initiation of regular hemodialysis were enrolled and divided into 2 groups (group A "good responder", 7 patients and group B "poor responder", 3 patients) in accordance to the response to rh-EPO therapy. Nuclear binding activity of NF-kappaB was determined in ex vivo isolated mononuclear cells before, 4 and 8 weeks after onset of regular hemodialysis and rh-EPO therapy by electrophoretic mobility shift assays (EMSA). In group A, a reduction of NF-KB binding activity from 100% to 56 +/- 6% was observed within the first four weeks of rh-EPO treatment, while mean hemoglobin rose from 8.2 +/- 0.4 g/dl to 11.1 +/- 0.2 g/dl. However, this effect was abrogated after another 4 weeks of treatment when NF-kappaB signal increased back to 85.2 +/- 10.6% despite consistent mean hemoglobin level of 11.3 +/- 0.4 g/dl. Group B demonstrated a slight increase of NF-kappaB signal from 100% to 129 +/- 18.5%, while mean hemoglobin only moderately rose from 7.6 +/- 0.3 g/dl to 8.3 +/- 0.1 g/dl within the first 4 weeks, and it further rose to 180 +/- 45% after 8 weeks of treatment, while mean hemoglobin (9.5 +/- 0.1 g/dl) remained low. The NF-kappaB binding activity differed significantly when comparing both groups (p = 0.007). Binding activity of Oct-1, serving as control, did not change notably in either group (p = 0.34). In vitro studies showed that rh-EPO did not directly affect NF-KB binding activity in THP-1 cells. However, coincubation of THP-1 cells with erythrocytes led to a reduction of NF-kappaB binding activity only in THP-1 cells with a hemoglobin level adjusted to 11 g/dl compared to 8 g/dl in the presence of rh-EPO. In vivo and in vitro data implicate a complex interaction between rh-EPO, stimulated RBC and the redox-sensitive transcription factor NF-kappaB in mononuclear cells.

Aged↗

PubMed1998

Study of erythrocytes, hemoglobin levels, and menstrual cycle characteristics of women exposed to aromatic hydrocarbons.

OBJECTIVES: The impact of occupational hazards on erythrocyte and hemoglobin levels and menstrual cycle characteristics in women exposed to aromatic hydrocarbons was studied. The investigated cohort consisted of 110 women exposed to benzene, toluene, xylene and styrene while working in the transport and storage of petrochemical products (TSPP), the laboratory for the control of aromatic hydrocarbons (LCAH), and rubber and latex (RL) production at the biggest petrochemical plant in Bulgaria, Neftochim. Controls consisted of 45 women from the administrative personnel in the same plant. METHODS: Questionnaires were administrated to all participants to obtain self-reported demographic data, data on characteristics of the menstrual cycle, and psychosomatic symptoms. Erythrocyte counts (RBC) and hemoglobin (HGB) levels were determined by the semiautomatic hematology analyzer Serono System 190, USA. All subjects had signed an informed consent. RESULTS: The mean RBC counts and HGB levels of the women from the LCAH and TSPP departments were statistically significantly lower than those of the control group. We found statistically significant differences in all exposed groups in comparison with controls when the dose-response relationship was investigated. No statistically significant differences were found in menstrual cycle characteristics (duration of the menstrual cycle, days and quantity of bleeding) between the subjects exposed and the controls in all age groups investigated, but the numbers were too small to allow definite conclusions. CONCLUSIONS: The lowering of HGB levels and RBC counts in the investigated women were mainly due to the direct influence of aromatic hydrocarbons in the working environment on hematopoiesis. The studied group was too small to enable us to determine the impact of aromatic hydrocarbons on menstrual cycle characteristics, and the possible combination of these effects.

Adult↗

PubMed2000

[Prognostic value of hemoglobin level for primary radiochemotherapy of head-neck carcinomas].

The pretherapeutic hemoglobin level (Hb) has been postulated to constitute a prognostic marker for outcome after primary chemoradiation of patients with advanced cancer of the head and neck. However, this hypothesis has not been tested systematically in large study samples. In the years 1992-1997, 125 patients with advanced head and neck cancer (stages III/IV UICC) were treated with primary chemoradiation in two different prospective multicentric trials, 62 patients in trial A (phase II, 1992-1995), and 63 in trial B (phase III, 1995-1997). Beside initial Hb, other pretherapeutic parameters with potential prognostic relevance were assessed and correlated with clinical outcome after 43-months follow-up: total tumor volume (TTV; calculated in initial CT scans), tumor oxygenation (polarographic measurements with Eppendorf histography), TNM, tumor localization, age, and performance status. The evaluation of the clinical end points (progression-free and overall survival and local tumor control) revealed that Hb and TTV were independent parameters with strong predictive character of outcome after primary chemoradiation in both trials (n = 125). Bivariate analysis showed < median (13.5 g/dl) a hazard ratio of 2.1 (P = 0.002) for Hb; and > median (98 ml) a Hazard ratio of 2.0 (P = 0.006) for TTV. Severe anemia (Hb < 10 g/dl) was an adverse factor in three patients. Hypoxia was associated with poorer initial therapeutical response but was not predictive of clinical outcome. Furthermore, tumor oxygenation showed no correlation with Hb. The other parameters examined failed to show prognostic significance. Our results indicate a high prognostic value of initial Hb for outcome after primary chemoradiation in advanced head and neck cancer and imply a therapeutic benefit of Hb substitution or erythropoietin administration. We propose to test this in randomized clinical trials.

Adult↗

PubMed1998

Relevance of oxygen in radiation oncology. Mechanisms of action, correlation to low hemoglobin levels.

At the beginning of this century Schwarz (1909) and Holthusen (1921) observed the influence of oxygen on the radiosensitivity of cells. In 1951 Hollaender et al. described that E. coli needed 3-fold higher radiation doses when treated under anoxic conditions compared to normoxic conditions. This led to the evaluation of the oxygen enhancement ratio (OER) for photons (X-rays), neutrons and heavy ions. It was found that the OER for conventional radiation therapy (RT) with photons is much higher (about 3) than the OER for neutron-RT (only 1.5) or heavy ions. According to a hypothesis free radicals which are produced by radiation are fixed in the presence of oxygen. Radicals are interacting with DNA, macromolecules and membranes. The DNA lesion can be followed by cell death. There is some evidence that tumor cells respond to hypoxia with the expression of a variety of genes coding for oxygen regulated proteins such as c-jun, VEGF or p53. Hypoxia also enhances the genetic instability of tumor cells. Oxygen tensions in malignant tumors can be determined under clinical routine conditions by using a computerized polarographic needle electrode system (Eppendorf, Hamburg, Germany). Several studies in the past years showed that tumors are in general more hypoxic than the surrounding normal tissue and that a marked variability of intra- as well as intertumoral pO2 values exist (for review see Vaupel and Höckel 1998). Moreover, it has been shown in different tumor entities that the oxygenation status influences the local control rate and overall survival. Furthermore, the oxygenation status obtained at one site (primary) is significantly related at other sites (lymph node metastases) in patients with squamous cell carcinoma of the head and neck (SCCHN). In addition, there is a significant correlation between hemoglobin level and tumor oxygenation in patients with SCCHN. There is some evidence that the oxygenation status can be improved by the correction of a low hemoglobin level and consequently, the curative chance might rise.

Cell Hypoxia↗

PubMed2001

[Hemoglobin level among infants in Akko sub-district].

OBJECTIVES: To determine the prevalence of anemia among infants born in 1995 within the Akko sub-district and to investigate the association between anemia and socio-demographic variables. SUBJECTS AND METHODS: In 1995, 7920 children were born in the Akko sub-district. Recommendations for prophylactic doses of iron preparations were given to all the infants aged 4-12 months screened by the "Mother and Child" clinic's team. Procedures at the "Mother and Child" clinic require the clinic's nurses to perform a routine hemoglobin test for each child at the age of 12 months. Anemia was defined as a level of hemoglobin less than 11 g/dl. The chi-square test was used for statistical analyses. RESULTS: A hemoglobin test was performed on 5703 infants. The finding showed that 30.8% of these infants had a hemoglobin level below 11 g/dl, 24% had a hemoglobin level between 10.0-10.9 g/dl, 6%--between 9.0-9.9 g/dl and less then 1% of the infants had a level of hemoglobin below 9.0 g/dl. Statistical analysis was performed on the results obtained from 5535 infants of non-Jewish origin. An association was found between the rate of anemia and ethnicity (Arabs more than Druze, p = 0.02) and between the rate of anemia and the type of settlement (p = 0.001). Arab settlements of higher socio-economic level showed a lower rate of anemia than those of low socio-economic level. The highest rate of anemia was found within Bedouin settlements. The number of children in the family was significantly associated with anemia rates (p = 0.0005), showing dose response effect. There was inverse correlation between maternal education and anemia rate (p = 0.001). No association was found between birth weight and anemia rates. CONCLUSIONS: A high rate of anemia was found among non-Jewish infants in the Akko sub-district. This finding indicates the necessity for an intervention program to reduce this high rate of anemia and its associated damage in order to facilitate the optimal psychomotor development of the children.

Anemia↗

PubMed2006

[Prognostic value of discharge hemoglobin level in patients hospitalized for acute heart failure].

INTRODUCTION AND OBJECTIVES: Recent studies show that the prevalence of anemia in patients with heart failure is high and indicate that its presence leads to increased mortality and morbidity. Our aims were to determine the prevalence of anemia in patients hospitalized for heart failure and to study the long-term prognostic significance of anemia by evaluating its relationship with mortality (total and due to heart failure) and readmission for heart failure. METHODS: The study included 242 consecutive patients admitted to our cardiology department and discharged with a diagnosis of congestive heart failure. The Kaplan-Meier technique and Cox regression modeling were used to determine whether anemia is an independent predictor of death or readmission for heart failure. Anemia was defined as a hemoglobin level <12 g/dL. The mean follow-up period was 23.5 (10.9) months. RESULTS: Overall, 79 patients (32.6%) were anemic. During follow-up, 77 died (53 due to heart disease) and 117 were readmitted for heart failure. Multivariate analysis showed that anemia was an independent predictor of death (hazard ratio [HR]=1.85, 95% confidence interval [CI], 1.12-3.06), death due to heart disease (HR=1.88, 95% CI, 1.03-3.45), and readmission for heart failure (HR=1.87, 95% CI, 1.28-2.74). CONCLUSIONS: The prevalence of anemia was high in patients hospitalized for heart failure. Moreover, a discharge hemoglobin level less than 12 g/dL was a predictor of all-cause death, cardiac death, and readmission for heart failure.

Adult↗

PubMed1990

Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus.

BACKGROUND: The value of routine measurements of glycosylated hemoglobin (hemoglobin A1c) in the care of patients with diabetes mellitus is uncertain. We undertook this study to determine whether knowledge of hemoglobin A1c values would result in improved metabolic control in a group of patients with insulin-dependent diabetes mellitus (IDDM). METHODS: We randomly assigned 240 patients with IDDM to one of two groups that were comparable in age, sex, duration of diabetes, and initial hemoglobin A1c levels. The patients were followed for a year, and the hemoglobin A1c concentration was measured at three-month intervals. The hemoglobin A1c values were used in assessing glycemic control and modifying therapy in one of the two groups. In the other, care givers were not aware of the hemoglobin A1c levels and relied on blood or urine glucose measurements to monitor treatment. RESULTS: Among the 222 patients still being followed after one year, the mean hemoglobin A1c value decreased significantly--from 10.1 to 9.5 percent (P less than 0.005)--in the group whose hemoglobin A1c level was monitored (n = 115), whereas the initial and one-year values in the control group (n = 107) were 10.0 and 10.1 percent, respectively. The proportion of patients with poor control, defined as those having a hemoglobin A1c value above 10.0 percent, decreased from 46 to 30 percent (P less than 0.01) in the group whose hemoglobin A1c level was monitored but did not change significantly (45 to 50 percent) in the control group. The patients in the group whose hemoglobin A1c level was monitored were seen and their insulin regimens changed more often, but they were hospitalized for acute care of their diabetes less often than those in the control group. A similar decrease in hemoglobin A1c values occurred in the control group in the following year, when their care givers knew their hemoglobin A1c values. CONCLUSIONS: Regular measurements of hemoglobin A1c lead to changes in diabetes treatment and improvement of metabolic control, indicated by a lowering of hemoglobin A1c values.

Diabetes Mellitus, Type 1↗

PubMed1975

Hemoglobin levels in persons of tibetan ancestry living at high altitude.

The mean hemoglobin level of persons of Tibetan ancestry living at 4000 m in the Nepal Himalayas was found similar to that expected at an altitude of 2300 m and an arterial O2 saturation of 92%. Plasma volumes were normal, and deficiency states and hemoglobinopathies were not significant. Possible reasons for this finding are discussed.

Adolescent↗

PubMed1981

Hemoglobin levels in normal Filipino pregnant women.

The hemoglobin concentrations during pregnancy in Filipinos belonging to the upper income group, who were prescribed 105 mg elemental iron daily, and who had acceptable levels of transferrin saturation, were examined in an attempt to define normal levels. The hemoglobin concentrations for each trimester followed a Gaussian distribution. The hemoglobin values equal to the mean minus one standard deviation were 11.4 gm/dl for the first trimester and 10.4 gm/dl for the second and third trimesters. Using these values as the lower limits of normal, in one group of pregnant women the prevalence of anemia during the last two trimesters was found lower than that obtained when WHO levels for normal were used. Groups of women with hemoglobin of 10.4 to 10.9 gm/dl (classified anemic by WHO criteria but normal in the present study) and those with 11.0 gm/dl and above could not be distinguished on the basis of their serum ferritin levels nor on the degree of decrease in their hemoglobin concentration during pregnancy. Many subjects in both groups, however, had serum ferritin levels less than 12 ng/ml which indicate poor iron stores. It might be desirable in future studies to determine the hemoglobin cut-off point that will delineate subjects who are both non-anemic and adequate in iron stores using serum ferritin levels as criterion for the latter.

Anemia↗

PubMed1999

Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.

Recent reports have suggested that pretreatment hemoglobin level (Hgb) is significantly associated with local control (LC) and overall survival (OS) in patients with T1 and T2 squamous cell carcinoma of the glottic larynx. To further evaluate the association of pretreatment Hgb level and other factors with outcome, we performed a retrospective review limited to patients with T1 squamous cell carcinoma of the glottic larynx treated with external beam radiation therapy. One-hundred thirty-nine patients with T1 squamous cell carcinoma of the glottic larynx were analyzed. Median follow-up was 5 years (range 2-22). Median pretreatment Hgb was 14.4 gm/dl (range 8.2-17.2). The following parameters were analyzed for their impact on LC, OS, and disease specific survival (DSS): age; gender; pretreatment Hgb; tumor grade; anterior commissure involvement; field size; total dose; dose per fraction; and overall treatment time. Five-year actuarial LC was 84%. Pretreatment Hgb was not a significant predictor for LC when assessed as a continuous variable (P = 0.38), nor as a dichotomous variable with a cutoff at 13 gm/dl. Local control was 82% for patients with Hgb >13 vs. 92% for Hgb < or = 13 (P= 0.13). No other factor was significant for LC. Five-year actuarial OS was 74%. Univariate analysis revealed that, pretreatment Hgb, total dose, and patient age were significant factors for OS. Overall survival was 78% for patients with pretreatment Hgb > 13 gm/dl vs. 68% for patients with Hgb < or = 13 gm/dl (P = 0.004). Overall survival was 77% for patients treated with > 66 Gy vs. 67% for those treated with < or =66 Gy (P = 0.0013), and 80% for patients < or =61 years as opposed to 69% for patients older than 61 years (P = 0.017). Multivariate analysis revealed that only age (P = 0.014) and Hgb concentration (P = 0.001) retained significance. Five-year actuarial DSS was 92%. Pretreatment Hgb was not a prognostic factor for DSS, nor were any other analyzed factors. Pretreatment Hgb is not a significant prognostic factor for LC in patients with T1 squamous cell carcinoma of the glottic larynx, but it does predict for a poorer OS without affecting DSS. This suggests that patients with lower pretreatment Hgb may have confounding medical problems that detract from their overall survival.

Actuarial Analysis↗

PubMed1986

Theoretical evaluation of expected changes in oxygenation of tumors associated with different hemoglobin levels.

A mathematical computer-based model was developed which analyzes the influence of hemoglobin concentration; shape of the oxygen dissociation curve; red cell velocity; capillary network geometry; and oxygen consumption on the oxygen partial pressure (PO2) distribution in tissue. In this study, the influence of acute hemoglobin concentration changes on the oxygen supply to tissue was analyzed. The specific question, whether moderate changes in the hemoglobin concentration of only 20% (e.g., from 15 g/dl to 12 g/dl i.e. baseline is 15 g/dl), as they may often occur clinically, are able to produce a significant change in the tissue oxygenation, was addressed. This is of importance for the estimation of the possible effects of blood transfusions prior to radiation therapy. The model predicts that even a moderate 20% increase in the hemoglobin concentration is able to decrease the anoxic tissue volume by 30%. The results indicate that hemoglobin levels should not be subnormal at the beginning of chemotherapy or radiotherapy. Transfusions or the application of artificial oxygen carriers could be helpful.

Hemoglobins↗

PubMed1998

Effects of increasing blood hemoglobin levels on systemic hemodynamics of acutely anemic cirrhotic patients.

BACKGROUND/AIMS: In experimental portal hypertension, blood hemoglobin levels have been shown to influence the hyperdynamic circulatory state. The aim of this study was to assess the hemodynamic effects of increasing hemoglobin concentration in human portal hypertension. METHODS: Sixteen cirrhotic patients recovering from a variceal bleeding episode were randomly assigned to receive two units of packed red cells or 500 ml of a protein solution. Systemic and portal hemodynamics, and rheological and hormonal parameters were measured at baseline and after expansion. RESULTS: Both groups were similar with respect to the degree of liver failure, severity of the bleeding episode, activation of the endogenous vasopressor systems, and hemodynamic parameters. The administration of either erythrocytes or a protein solution prompted a similar increase in total blood volume and suppression of vasopressor systems. Both groups of patients experienced similar increases in wedged hepatic venous pressure. Hepatic venous pressure gradient was not significantly modified but tended to increase in erythrocyte-transfused patients. Cardiopulmonary pressures increased, but this increment was significant in the non-blood-transfused patients only. Cardiac output decreased in erythrocyte-transfused patients, while it increased in the group receiving a protein solution. Red blood cell transfusion resulted in an increase in systemic vascular hindrance (resistance/blood viscosity), whereas the administration of a protein solution prompted a decrease in this parameter, thus reflecting true vasoconstriction and vasodilation, respectively. CONCLUSIONS: An increase in blood hemoglobin in acutely anemic cirrhotic patients attenuates their hyperdynamic circulation beyond viscosity-dependent changes, an effect which might be counteracted by the effects on portal venous pressure gradient.

Aged↗

PubMed1989

The effect of vitamin E on glycosylated hemoglobin levels in diabetic rats: a preliminary report.

The effect of vitamin E (D-alpha-tocopherol acetate) on glycosylated hemoglobin levels was investigated in streptozotocin-diabetic rats. The animals were divided into four groups: (a) Group 1: control group, (b) Group 2: diabetic group, (c) Group 3: diabetic group treated with low-dose vitamin E and (d) Group 4: diabetic group treated with high-dose vitamin E. Starting 24 hr after streptozotocin injections (60 mg/kg), Groups 3 and 4 received intraperitoneal injections of vitamin E on days 1, 4, 7, 11, 14, 18 and 21 at doses of 500 mg/kg and 1,000 mg/kg respectively. Vitamin E treatment did not prevent weight loss or improve glycemic control in diabetic animals but significantly suppressed the increase in glycosylated hemoglobin in Group 4 (7.7 +/- 0.6 mumols fructose/g hemoglobin versus 5.5 +/- 0.2 mumols fructose/g hemoglobin in Group 2 and Group 4 respectively). These levels were still significantly higher than the levels in healthy control group animals (2.6 +/- 0.1 mumols fructose/g hemoglobin). Further studies on the suppressive effect of vitamin E are warranted.

Animals↗

PubMed1987

Adult hemoglobin levels in newborn babies from different countries and in babies with some significant hemoglobinopathies.

The level of adult hemoglobin (Hb A, Hb S, Hb C, Hb E) was determined in cord blood samples of 66 Black babies (41 with four alpha-globin genes; 25 with two alpha-globin genes) with Hb A, of 51 SS, 7 CC, and 6 EE babies, of 359 babies from Mediterranean countries, and 197 babies from Japan and China. Methodology involved high-performance liquid chromatographic procedures, which are considered most accurate because of a complete separation of Hb F (or gamma chains) and the adult hemoglobins (or beta A or beta X chains). The presence of an alpha 2-thalassemia homozygosity (-alpha/ -alpha versus alpha alpha/alpha alpha) did not affect the average Hb A level. The levels of Hb S and Hb E in homozygous Hb S or Hb E babies were about one-third lower than the Hb A of the normal baby, while that of Hb C in homozygous Hb C babies was not decreased. The average level of Hb A in Chinese (50 babies) and Japanese (147 babies) was about 16.0%, which was significantly lower than the average level of 19.0% in newborns of Italian (221 babies), Yugoslavian (68 babies), and Turkish (70 babies) origin.

Fetal Blood↗

PubMed1998

Low density lipoprotein particle size is associated with glycosylated hemoglobin levels regardless of plasma lipid levels.

We evaluated the influence of the levels of glycosylated hemoglobin (HbA1C) and fasting plasma glucose on the variation in low density lipoprotein (LDL) peak particle size in 210 subjects who were undergoing an annual check-up. Univariate analysis showed that LDL particle size was significantly and positively correlated with high density lipoprotein (HDL) cholesterol levels, and was inversely correlated with the levels of total plasma cholesterol, triglycerides, fasting glucose, fasting insulin, HbA1C, and body mass index (BMI). Stepwise regression analysis selected four independent contributing variables that could affect LDL particle size; triglyceride levels, HDL cholesterol levels, LDL cholesterol levels, and HbA1C levels. Similar regression analysis performed for men and for normotensive subjects showed that HbA1C levels also independently influenced LDL particle size. The results indicate that HbA1C levels have a significant effect on LDL particle size. This suggests that small LDL particles would be present in subjects with non-insulin-dependent diabetes mellitus regardless of plasma lipid concentrations.

Adult↗

PubMed1998

Glycated hemoglobin levels and their correlation with atherosclerotic risk factors in a Japanese population--the Jichi Medical School Cohort Study 1993-1995.

We conducted a large population-based study to assess levels of glycated hemoglobin A1c (HbA1c) and to evaluate the correlation between HbA1c and other cardiovascular risk factors in Japan. A total of 910 men and 1,890 women aged 30-69 years participated in the Jichi Medical School Cohort Study (1993-95). Mean HbA1c was 5.61% in men and 5.49% in women. HbA1c levels were significantly correlated with levels of triglycerides, fibrinogen, and factor VII, and inversely correlated with high-density lipoprotein (HDL)-cholesterol level in both sexes. Lipoprotein(a) was inversely correlated in men. Blood pressure, body mass index (BMI), and total cholesterol were significantly associated with HbA1c in women. After adjusting for significant variables in univariate analyses, fibrinogen and factor VII remained as significant correlates in men, and BMI and total cholesterol in women. The authors conclude that HbA1c level is correlated not only with classical cardiovascular risk factors, but also with fibrinogen and factor VII. Our results suggest that HbA1c could be an alternative to blood glucose in evaluating atherosclerotic risk in a large-sized population study.

Adult↗